NCT03345797 - Evaluation of Testosterone Nasal Gel in Hypogonadal Boys | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

April 11, 2020

Study Completion Date

April 11, 2022

Conditions

Hypogonadism

Interventions

DRUG

Testosterone Nasal Gel [Natesto]

nasal gel containing 4.5% w/w testosterone

Trial Locations (3)

University of Glasgow, Royal Hospital for Children, Glasgow

Cambridge University Hospital's NHS Foundation Trust, Cambridge

Alder Hey Children's Hospital, Liverpool